New Lifetime High For Becton Dickinson (BDX)
Trade-Ideas LLC identified
(
) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Becton Dickinson as such a stock due to the following factors:
- BDX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $182.6 million.
- BDX has traded 10,141 shares today.
- BDX is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in BDX with the Ticky from Trade-Ideas. See the FREE profile for BDX NOW at Trade-Ideas
More details on BDX:
Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The stock currently has a dividend yield of 1.5%. BDX has a PE ratio of 47. Currently there are 9 analysts that rate Becton Dickinson a buy, no analysts rate it a sell, and 5 rate it a hold.
The average volume for Becton Dickinson has been 950,300 shares per day over the past 30 days. Becton Dickinson has a market cap of $36.5 billion and is part of the health care sector and health services industry. The stock has a beta of 1.01 and a short float of 1.3% with 2.66 days to cover. Shares are up 12.4% year-to-date as of the close of trading on Thursday.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Analysis:
rates Becton Dickinson as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, increase in net income, good cash flow from operations and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
Highlights from the ratings report include:
- The revenue growth greatly exceeded the industry average of 7.9%. Since the same quarter one year prior, revenues rose by 49.6%. Growth in the company's revenue appears to have helped boost the earnings per share.
- Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company's strong earnings growth was key. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
- The net income growth from the same quarter one year ago has greatly exceeded that of the S&P 500, but is less than that of the Health Care Equipment & Supplies industry average. The net income increased by 56.5% when compared to the same quarter one year prior, rising from $216.00 million to $338.00 million.
- Net operating cash flow has significantly increased by 144.29% to $557.00 million when compared to the same quarter last year. In addition, BECTON DICKINSON & CO has also vastly surpassed the industry average cash flow growth rate of -11.82%.
- BECTON DICKINSON & CO has improved earnings per share by 44.4% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, BECTON DICKINSON & CO reported lower earnings of $3.41 versus $6.00 in the prior year. This year, the market expects an improvement in earnings ($8.55 versus $3.41).
- You can view the full Becton Dickinson Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.